Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Swardfager, W

Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. [electronic resource] - Neuroscience and biobehavioral reviews 04 2018 - 56-66 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

1873-7528

10.1016/j.neubiorev.2018.01.010 doi


Animals
Anti-Inflammatory Agents--therapeutic use
Comorbidity
Epoxide Hydrolases--antagonists & inhibitors
Humans
Inflammation--complications
Mental Disorders--complications
Oxidative Stress
Vascular Diseases--complications